Genedrive (GDR) Given Buy Rating at Peel Hunt

Peel Hunt restated their buy rating on shares of Genedrive (LON:GDR) in a report issued on Tuesday morning. They currently have a GBX 152 ($2.10) price objective on the stock.

Genedrive (GDR) opened at GBX 35 ($0.48) on Tuesday. Genedrive has a fifty-two week low of GBX 25 ($0.35) and a fifty-two week high of GBX 44.50 ($0.61). The company has a market capitalization of $5.75 and a price-to-earnings ratio of -100.00.

TRADEMARK VIOLATION NOTICE: This story was originally published by Week Herald and is owned by of Week Herald. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at

Genedrive Company Profile

Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia.

Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with's FREE daily email newsletter.

Leave a Reply